Related Experiment Video
Updated: Jun 23, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
[Stroke prevention in sickle-cell disease: results, hurdles and future perspectives]
Françoise Bernaudin1, Suzanne Verlhac
1Hématologie-Pédiatrie, Hôpital Intercommunal de Créteil, 40 avenue de Verdun 94000 Créteil.
Insights
Stroke is a serious complication of sickle cell disease (SCD). Transcranial Doppler (TCD) screening in infants detects cerebral vasculopathy, and early intervention significantly reduces stroke risk.
Area of Science:
- Pediatric Neurology
- Hematology
- Vascular Medicine
Background:
- Sickle cell disease (SCD) is the leading cause of stroke in infants.
- Stroke represents the most severe complication of SCD in children.
- Proximal vasculopathy accounts for 75% of SCD-related strokes, often progressive.
Purpose of the Study:
- To evaluate the effectiveness of transcranial Doppler (TCD) screening for detecting cerebral vasculopathy in infants with SCD.
- To assess the impact of early intervention, including transfusion programs, on stroke risk reduction in children with SCD.
- To explore the role of stem cell transplantation as a curative treatment for high-risk SCD patients.
Main Methods:
- Utilized transcranial Doppler (TCD) to screen for cerebral vasculopathy in infants with SCD.
- Implemented transfusion programs to maintain HbS levels below 30% in at-risk children.
- Analyzed stroke incidence in a cohort of screened SCD newborns compared to historical data.
Main Results:
- High TCD velocities (> 2 m/s) indicate a 40% stroke risk within 36 months.
- Transfusion programs reduced stroke risk from 11% to under 2% in screened SCD patients.
- The implemented screening and intervention strategy reduced stroke risk to less than 2% by age 18.
Conclusions:
- Routine TCD screening at 12-18 months is crucial for early detection of cerebral vasculopathy in children with SCD.
- Proactive management, including transfusions, dramatically lowers stroke risk.
- Genoidentical stem cell transplantation offers a high chance of cure and should be considered for high-risk individuals.
Abstract:
Sickle cell disease (SCD) is the most frequent cause of stroke during infancy, and stroke is the most serious complication of SCD in children. Sludge-induced distal vasculopathy explains 25% of strokes in SCD, while proximal vasculopathy is responsible for 75% of cases. The stenoses observed in SCD-related proximal vasculopathy are progressive and can be detected by transcranial Doppler (TCD), a reliable, non-invasive and low-cost imaging method. High velocities (> 2 mls) are associated with a 40% risk of stroke within 36 months, but initiation of a transfusion program maintaining the HbS level under 30% reduces the risk to less than 2%. TCD must be performed in all children at 12-18 months of age to detect cerebral vasculopathy and prevent stroke. This approach has been adopted in our institution, based on a cohort of SCD newborns screened at birth: the risk of stroke was reduced from the expected 11% to less than 2% at 18 years. Genoidentical stem cell transplantation, which safely obviates the need for transfusion programs and provides a 95% chance of cure, should be offered early to patients at risk of stroke. When possible, sibling cord blood cryopreservation is recommended
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
iPS Cell Differentiation
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Peripheral Artery Disease IV: Nursing Management
